UK patient groups say that pharma could be more transparent
An independent study of the views of 83 UK-based patient [...]
Kidney cancer vaccine abandoned after failure of phase 3 clinical trial
Argos Therapeutics has abandoned its phase 3 trial of rocapuldencel-T (a [...]
FDA grants fast track designation to glutaminase inhibitor CB-839 in combination with cabozantinib for metastatic kidney cancer
Calithera Biosciences announced earlier this week that the US Food [...]
How premature hype about drugs in clinical trials fails patients
This is an interesting blog from a cancer doctor who [...]
Kidney cancer may begin to develop in childhood
Scientists working on a Cancer Research UK funded study have [...]
Axitinib fails as an adjuvant therapy for high risk kidney cancer
The phase 3 ATLAS clinical trial to assess axitinib as [...]
Alternative 2 weeks on/1 week off dosing schedule for sunitinib
The results from a phase 2 study looking at the [...]
FDA approves nivolumab-ipilimumab combination for advanced kidney cancer
The US Food and Drug Administration (FDA) has granted approval [...]
‘One-stop shops’ for earlier cancer diagnosis
NHS England are introducing "one-stop shops" aimed at speeding up [...]
Anticancer immunotherapy that overcomes tumour resistance to immune checkpoint inhibitors
Despite some remarkable patient outcomes in recent years, most tumours [...]
